Evidence map›Paper›PMID 32562338›Full record

ArticleJournal of the International AIDS Society2020

Recommendations for the use of mathematical modelling to support decision-making on integration of non-communicable diseases into HIV care.

Joseph Kibachio, Valerian Mwenda, Oren Ombiro, Jamima H Kamano, Pablo N Perez-Guzman, Kennedy K Mutai, Idris Guessous, David Beran, Paratsu Kasaie, Brian Weir and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Joseph KibachioDivision of Non-communicable Diseases, Ministry of Health, Kenya.
Valerian MwendaDivision of Non-communicable Diseases, Ministry of Health, Kenya.
Oren OmbiroDivision of Non-communicable Diseases, Ministry of Health, Kenya.
Jamima H KamanoDepartment of Medicine, Moi University School of Medicine, Kenya, Eldoret.
Pablo N Perez-GuzmanMRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Kennedy K MutaiNational AIDS Control Council, Kenya, London.
Idris GuessousDivision of Primary Care Medicine, Geneva University Hospital and University of Geneva, Geneva, Switzerland.
David BeranDivision of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland.
Paratsu KasaieJohn Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-3744-9501
Brian WeirJohn Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Blythe BeecroftFogarty International Center, National Institutes of Health, Bethesda, MD, USA.
Nduku KilonzoNational AIDS Control Council, Kenya, London.
Linda KupferFogarty International Center, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-6886-6818
Mikaela SmitMRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.ORCID 0000-0001-8530-748X
University of Geneva · CHJohns Hopkins University · USLondon Centre for Neglected Tropical Disease Research · GBMinistry of Health · KENational Aids Control Council · KENational Institutes of Health · USMoi University · KE

Funding

Projecting the Epidemiologic and Economic Impact of HIV Prevention Efforts in the Context of Other Sexually Transmitted InfectionsK01AI138853 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KASAIE, PARASTU · 2019 to 2023
$591k
Quantify and prepare for the double infectious and non-communicable disease burden in Zimbabwe.R21AG053093 · NIA · IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE · PI HALLETT, TIMOTHY · 2016 to 2017
$288k
Medical Research Council OISE-9531011NIAID NIH HHS K01 AI138853NIA NIH HHS R21 AG053093NIH HHS 1R21AG053093-01
6 · The paper itself

Abstract

introductionIntegrating services for non-communicable diseases (NCDs) into existing primary care platforms such as HIV programmes has been recommended as a way of strengthening health systems, reducing redundancies and leveraging existing systems to rapidly scale-up underdeveloped programmes. Mathematical modelling provides a powerful tool to address questions around priorities, optimization and implementation of such programmes. In this study, we examine the case for NCD-HIV integration, use Kenya as a case-study to highlight how modelling has supported wider policy formulation and decision-making in healthcare and to collate stakeholders' recommendations on use of models for NCD-HIV integration decision-making. DISCUSSION: Across Africa, NCDs are increasingly posing challenges for health systems, which historically focused on the care of acute and infectious conditions. Pilot programmes using integrated care services have generated advantages for both provider and user, been cost-effective, practical and achieve rapid coverage scale-up. The shared chronic nature of NCDs and HIV means that many operational approaches and infrastructure developed for HIV programmes apply to NCDs, suggesting this to be a cost-effective and sustainable policy option for countries with large HIV programmes and small, un-resourced NCD programmes. However, the vertical nature of current disease programmes, policy financing and operations operate as barriers to NCD-HIV integration. Modelling has successfully been used to inform health decision-making across a number of disease areas and in a number of ways. Examples from Kenya include (i) estimating current and future disease burden to set priorities for public health interventions, (ii) forecasting the requisite investments by government, (iii) comparing the impact of different integration approaches, (iv) performing cost-benefit analysis for integration and (v) evaluating health system capacity needs.

conclusionsModelling can and should play an integral part in the decision-making processes for health in general and NCD-HIV integration specifically. It is especially useful where little data is available. The successful use of modelling to inform decision-making will depend on several factors including policy makers' comfort with and understanding of models and their uncertainties, modellers understanding of national priorities, funding opportunities and building local modelling capacity to ensure sustainability.

Indexed as

Decision MakingDelivery of Health Care, IntegratedModels, BiologicalDelivery of Health CareGovernment ProgramsHIV InfectionsHumansKenyaModels, TheoreticalNoncommunicable DiseasesPrimary Health CareHIVintegrationKenyamodellingnon-communicable diseasespolicy

Identifiers

PMID32562338
PMCPMC7305412
OpenAlexW3036598870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.